Comorbidity and health care visit burden in working-age commercially insured patients with diabetic macular edema
Szilárd Kiss,1 Hitesh S Chandwani,2 Ashley L Cole,2 Vaishali D Patel,2 Orsolya E Lunacsek,3 Pravin U Dugel4 1Department of Ophthalmology, Weill Cornell Medical College, New York, NY, 2Global Health Economics and Outcomes Research, Allergan, Inc., Irvine, CA, 3Global Health Economics and...
Enregistré dans:
Auteurs principaux: | Kiss S, Chandwani HS, Cole AL, Patel VD, Lunacsek OE, Dugel PU |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5e1c11b834e34c69aeb3400f3071287b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
par: Javier Obis, et autres
Publié: (2021) -
Pseudophakic cystoid macular edema: update 2016
par: Grzybowski A, et autres
Publié: (2016) -
Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
par: Jumper JM, et autres
Publié: (2018) -
Long-term outcomes of intended undercorrection intraocular lens implantation in pediatric cataract
par: Lekskul A, et autres
Publié: (2018) -
Assessment of Post-Operative Pseudophakic Glaucoma by Ultrasound Biomicroscopy
par: Ragab IT, et autres
Publié: (2020)